Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-06-25

Clinical Trial Update: A Randomised, Double-Blind, Placebo-Controlled Study Assessing the Effect of Fenofibrate, Coenzyme Q10 and Their co-Administration on Ventricular Diastolic Function in Patients With Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 randomized, double-blind, placebo-controlled study evaluating fenofibrate, coenzyme Q10, and their combination on ventricular diastolic function in pati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Coenzyme Q10 (Coenzyme Q10)
  • FENOFIBRATE (Fenofibrate)

Snippet

Sponsor: Solvay Pharmaceuticals | Conditions: Patients With Type 2 Diabetes | Phase 2 | Status: COMPLETED